BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

526 related articles for article (PubMed ID: 15477435)

  • 21. Glucose metabolism and insulin therapy.
    Langouche L; Van den Berghe G
    Crit Care Clin; 2006 Jan; 22(1):119-29, vii. PubMed ID: 16399023
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and tolerability of alosetron for the treatment of irritable bowel syndrome in women and men: a meta-analysis of eight randomized, placebo-controlled, 12-week trials.
    Rahimi R; Nikfar S; Abdollahi M
    Clin Ther; 2008 May; 30(5):884-901. PubMed ID: 18555935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin strategies for managing inpatient and outpatient hyperglycemia and diabetes.
    Moghissi ES
    Mt Sinai J Med; 2008 Dec; 75(6):558-66. PubMed ID: 19021195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glucose normalization and outcomes in patients with acute myocardial infarction.
    Kosiborod M; Inzucchi SE; Krumholz HM; Masoudi FA; Goyal A; Xiao L; Jones PG; Fiske S; Spertus JA
    Arch Intern Med; 2009 Mar; 169(5):438-46. PubMed ID: 19273773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exogenous glucagon-like peptide-1 for hyperglycemia in critically ill patients.
    Pinelli NR; Jones MC; Monday LM; Smith Z; Rhoney DH
    Ann Pharmacother; 2012 Jan; 46(1):124-9. PubMed ID: 22202493
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of premorbid diabetic status on the relationship between the three domains of glycemic control and mortality in critically ill patients.
    Krinsley JS; Meyfroidt G; van den Berghe G; Egi M; Bellomo R
    Curr Opin Clin Nutr Metab Care; 2012 Mar; 15(2):151-60. PubMed ID: 22234163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glucose-insulin-potassium infusion as adjunctive therapy in myocardial infarction: current evidence and potential mechanisms.
    Timmer JR; van der Horst IC; Ottervanger JP; De Luca G; van 't Hof AW; Bilo HJ; Zijlstra F
    Ital Heart J; 2004 Oct; 5(10):727-31. PubMed ID: 15626267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A literature review of intensive insulin therapy and mortality in critically ill patients.
    Chen L
    Clin Nurse Spec; 2010; 24(2):80-6. PubMed ID: 20168143
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glucose-insulin-potassium therapy in adult patients undergoing cardiac surgery: a meta-analysis.
    Fan Y; Zhang AM; Xiao YB; Weng YG; Hetzer R
    Eur J Cardiothorac Surg; 2011 Jul; 40(1):192-9. PubMed ID: 21075642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glycemic control, mortality, and hypoglycemia in critically ill patients: a systematic review and network meta-analysis of randomized controlled trials.
    Yamada T; Shojima N; Noma H; Yamauchi T; Kadowaki T
    Intensive Care Med; 2017 Jan; 43(1):1-15. PubMed ID: 27637719
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of intensive insulin therapy for the management of glycemic control in hospitalized patients: a clinical practice guideline from the American College of Physicians.
    Qaseem A; Humphrey LL; Chou R; Snow V; Shekelle P;
    Ann Intern Med; 2011 Feb; 154(4):260-7. PubMed ID: 21320941
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inpatient management of diabetes mellitus.
    Bhoraskar A
    J Assoc Physicians India; 2011 Apr; 59 Suppl():29-31. PubMed ID: 21818996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention of cardiovascular disease through glycemic control in type 2 diabetes: a meta-analysis of randomized clinical trials.
    Mannucci E; Monami M; Lamanna C; Gori F; Marchionni N
    Nutr Metab Cardiovasc Dis; 2009 Nov; 19(9):604-12. PubMed ID: 19427768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Understanding glycemic control in the critically ill: 2011 update.
    Krinsley JS
    Hosp Pract (1995); 2011 Apr; 39(2):47-55. PubMed ID: 21576897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The place for glycemic control in the surgical patient.
    May AK; Kauffmann RM; Collier BR
    Surg Infect (Larchmt); 2011 Oct; 12(5):405-18. PubMed ID: 22004441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Benefits and risks of tight glucose control in critically ill adults: a meta-analysis.
    Wiener RS; Wiener DC; Larson RJ
    JAMA; 2008 Aug; 300(8):933-44. PubMed ID: 18728267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of hyperglycemia in acute illness: supporting evidence and its limitations.
    Corathers SD; Falciglia M
    Nutrition; 2011 Mar; 27(3):276-81. PubMed ID: 20869205
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Levosimendan reduces mortality in critically ill patients. A meta-analysis of randomized controlled studies.
    Landoni G; Mizzi A; Biondi-Zoccai G; Bignami E; Prati P; Ajello V; Marino G; Guarracino F; Zangrillo A
    Minerva Anestesiol; 2010 Apr; 76(4):276-86. PubMed ID: 20332741
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intensive insulin treatment.
    Merz TM; Finfer S
    Minerva Anestesiol; 2009 Dec; 75(12):703-9. PubMed ID: 19940823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Initial management of septic patients with hyperglycemia in the noncritical care inpatient setting.
    Schuetz P; Kennedy M; Lucas JM; Howell MD; Aird WC; Yealy DM; Shapiro NI
    Am J Med; 2012 Jul; 125(7):670-8. PubMed ID: 22608986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.